Effects of coffee on inflammatory cytokine gene expression in mice fed high-fat diets

Journal of Agricultural and Food Chemistry

Volumn 57, Issue 23, 2009, Pages 11100-11105

  Fukushima, Yoichi ^a   Kasuga, Masato ^b   Nakao, Kazuwa ^c   Shimomura, Iichiro ^d   Matsuzawa, Yuji ^e  

^a All Japan Coffee Association   (Japan)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e OSAKA UNIVERSITY   (Japan)

Author keywords

Coffee; Gene expression; High fat diet; Inflammatory cytokine; Mouse

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CYTOKINE;

ADIPOSE TISSUE; ANIMAL; ARTICLE; BLOOD; BODY WEIGHT; C57BL MOUSE; COFFEE; DISEASE MODEL; EATING; FAT INTAKE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; LIVER; MALE; METABOLIC SYNDROME X; MOUSE; PATHOPHYSIOLOGY; RANDOMIZATION;

ADIPOSE TISSUE; ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; BODY WEIGHT; COFFEE; CYTOKINES; DIETARY FATS; DISEASE MODELS, ANIMAL; EATING; GENE EXPRESSION REGULATION; HUMANS; LIVER; MALE; METABOLIC SYNDROME X; MICE; MICE, INBRED C57BL; RANDOM ALLOCATION;

MUS;

EID: 72449169419     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf901278u     Document Type: Article

References (45)

1. Zimmet, P.; Magliano, D.; Matsuzawa, Y.; Alberti, G.; Shaw, J. The metabolic syndrome: A global public health problem and a new definition. J. Atheroscler. Thromb. 2005, 12, 295-300.
2. Arai, H.; Yamamoto, A.; Matsuzawa, Y.; Saito, Y.; Yamada, N.; Oikawa, S.; Mabuchi, H.; Teramoto, T.; Sasaki, J.; Nakaya, N.; Itakura, H.; Ishikawa, Y.; Ouchi, Y.; Horibe, H.; Shirahashi, N.; Kita, T. Prevalence of metabolic syndrome in the general Japanese population in 2000. J. Atheroscler. Thromb. 2006, 202-208.
3. Matsuzawa, Y. Therapy Insight: Adipocytokines in metabolic syndrome and related cardiovascular disease, Nat. Clin. Pract. Cardiovasc. Med. 2006, 3, 35-42.
4. Zimmet, P.; Alberti, K. G.; Shaw, J. Global and societal implications of the diabetes epidemic. Nature 2001, 414, 782-787.
5. Sicree, R.; Shaw, J. E.; Zimmet, P. Z. The global burden of diabetes. In Diabetes Atlas, 2nd ed.; Gan, D., Ed.; International Diabetes Federation: Brussels, 2003; pp 15-71.
6. (6) van Dam, R. M.; Feskens, E. J. Coffee consumption and risk of type 2 diabetes mellitus, Lancet 2002, 360, 1477-1478. (Pubitemid 35356327)
7. (7) Yoshioka, K; Kogurea, A; Yoshidaa, T; Yoshikawa, T. Coffee consumption and risk of type 2 diabetes mellitus. Lancet 2002, 360, 1477-1478. (Pubitemid 35356327)
8. Isogawa, A.; Noda, M.; Takahashi, Y.; Kadowaki, T.; Tsugane, S. Coffee consumption and risk of type 2 diabetes mellitus. Lancet 2003, 361, 703-704.
9. Iso, H.; Date, C.; Wakai, K.; Fukui, M.; Tamakoshi, A.; JACC Study Group. The relationship between green tea and total caffeine intake and risk for self-reported type 2 diabetes among Japanese adults, Ann. Intern. Med. 2006, 144, 554-562.
10. (10) van Dam, R. M.; Hu, F. B. Coffee consumption and risk of type 2 diabetes: A systematic review. JAMA. J. Am. Med. Assoc. 2005, 294, 97-104. (Pubitemid 41002844)
11. Paynter, N. P.; Yeh, H. C.; Voutilainen, S.; Schmidt, M. L.; Heiss, G.; Folsom, A. R.; Brancati, F. L.; Linda, Kao, W. H. Coffee and sweetened beverage consumption and the risk of type 2 diabetes mellitus. Am. J. Epidemiol. 2006, 164, 1075-1084.
12. Hu, G.; Jousilahti, P.; Peltonen, M.; Bidel, S.; Tuomilehto, J. Joint association of coffee consumption and other factors to the risk of type 2 diabetes: Aprospective study in. Finland. Int J. Obes. 2006, 30, 1742-11729
13. (13) van Dam, R. M.; Willett, W. C.; Manson, J. E.; Hu, F. B. Coffee, caffeine, and risk of type 2 diabetes: A prospective cohort study in younger and middle-aged U.S. women. Diabetes Care. 2006, 29, 398-403. (Pubitemid 44106525)
14. (14) Keijzers, G. B.; De Galan, B. E.; Tack, C. J.; Smits, P. Caffeine can decrease insulin sensitivity in humans, Diabetes Care 2002, 25 (2), 364-369. (Pubitemid 41079637)
15. Salazar-Martinez, E.; Willett, W. C.; Ascherio, A; Manson, J. E.; Leitzmann, M. F.; Stampfer, M., J.; Hu, F. B. Coffee consumption and risk for type 2 diabetes mellitus, Ann. Intern. Med. 2004, 140, 1-8.
16. (16) Yamaji, T.; Mizoue, T.; Tabata, S.; Ogawa, S.; Yamaguchi, K.; Shimizu, E.; Mineshita, M.; Kono, S. Coffee consumption and glucose tolerance status in middle-aged Japanese men. Diahetoloeia 2004, 47, 2145-2151. (Pubitemid 40174687)
17. (17) Robertson, D.; Wade, D.; Workman, R.; Woosley, R. L.; Oates, J. A. Tolerance to the humoral and hemodynamic effects of caffeine in man. J. Clin. Invest. 1981, 67,1111-1117. (Pubitemid 11090551)
18. (18) Astrup, A.; Toubro, S.; Cannon, S.; Hein, P.; Breum, L.; Madsen, J. Caffeine: A double-blind, placebo-controlled study of its thermogenic, metabolic, and cardiovascular effects in healthy volunteers. Am. J. Clin. Nutr. 1990, 51, 759-767. (Pubitemid 20160962)
19. (19) Acheson, K. J.; Gremaud, G.; Meirim, I.; Montigon, F.; Krebs, Y.; Fay, L. B.; Gay, L. J.; Schneiter, P.; Schindler, C.; Tappy, L. Metabolie effects of caffeine in humans: Lipid oxidation or futile cycling? Am. J. Clin. Nutr. 2004, 79,40-46. (Pubitemid 41132060)
20. (20) van Dam, R. M.; Willett, W. C.; Manson, J. E.; Hu, F. B. Coffee, caffeine, and risk of type 2 diabetes: A prospective cohort study in younger and middle-aged U.S. women. Diabetes Care 2006, 29 (2), 398-403. (Pubitemid 44106525)
21. Scalbert, A.; Williamson, G. Dietary intake and bioavailability of polyphenols. J. Nutr. 2000, 130, 2073S-2085S.
22. (22) Nourooz-Zadeh, J.; Rahimi, A.; Tajaddini-Sarmadi, J.; Tritschler, H.; Rosen, P.; Halliwell, B.; Betteridge, D. J. Relationships between plasma measures of oxidative stress and metabolic control in NIDDM, Diabetologia 1997, 40, 647-653. (Pubitemid 27288109)
23. Fukushima, Y.; Ohie, T.; Yonekawa, Y.; Yonemoto, K.; Aizawa, H.; Mori, Y.; Watanabe, M.; Takeuchi, M.; Hasegawa, M.; Taguchi, C.; Kondo, K. Coffee and green tea as a large source of antioxidant polyphenols in the Japanese population. J. Agric. Food. Chem. 2009, 57, 1253-1259.
24. Matsuzawa, Y.; Funahashi, T.; Nakamura, T. Molecular mechanism of metabolic syndrome X: Contribution of adipocytokines adipocyte-derived bioactive substances, Ann. N. Y. Acad. Sci. 1999, 892, 146-154.
25. (25) Dandona, P.; Aijada, A.; Bandyopadhyay, A. Inflammation: The link between insulin resistance, obesity and diabetes. Trends Immypol. 2004, 25, 4-7. (Pubitemid 38032801)
26. (26) Weisberg, S. P.; McCann, D.; Desai, M.; Rosenbaum, M,; Leibel, R. L.; Ferrante, A. W., Jr. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 2003, 112, 1796-1808. (Pubitemid 38063703)
27. Clement, K,; Viguerie, N.;Poitou, C.; Carette, C.; Pelloux, V.;Curat, C. A.; Sicard, A.; Rome, S.; Benis, A.; Zucker, J. D.; Vidal, H.; Laville, M.; Barsh, G. S.; Basdevant, A.; Stich, V.; Cancello, R.; Langin, D. Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects. FASEB J. 2004, 18, 1657-1669.
28. (28) Xu, H.; Barnes, G. T.; Yang, Q.; Tan, G.; Yang, D.; Chou, C. J.; Sole, J.; Nichols, A.; Ross, J. S.; Tartaglia, L. A.; Chen, H. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 2003, 112, 1821-1830. (Pubitemid 38063705)
29. (29) Sartipy, P.; Loskutoff, D. J. Monocyte chemoattractant protein 1 in. obesity and insulin resistance. Proc. Natl. Acad. Sci. U.S.A. 2003, 100, 7265-7270. (Pubitemid 36706427)
30. Gu, L.; Okada, Y.; Clinton, S. K.; Gerard, C.; Sukhova, G. K.; Libby, P.; Rollins, B. J. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein, receptor-deficient mice. Mol. Cell 1998, 2, 275-281.
31. Gosling, J.; Slaymaker, S.; Gu, L.; Tseng, S.; Zlot, C. H.; Young, S. G.; Rollins, B. J.; Charo, I. F. MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. J. Clin Invest. 1999, 103, 773-778.
32. (32) Kanda, H.; Tateya, S.; Tamori, Y.; Kotani, K.; Hiasa, K.; Kitazawa, R.; Kitazawa, S.; Miyachi, H.; Maeda, S.; Egashira, K.; Kasuga, M. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J. Clin. Invest. 2006, 116, 1494-1505. (Pubitemid 43911004)
33. Acheson, K. J.; Zahorska-Markiewicz, B.; Pittet, P.; Anantharaman, K.; Jéquier, E. Caffeine and coffee: Their influence on metabolic rate and substrate utilization in normal weight and obese individuals. Am. J. Clin. Nutr. 1980, 33, 989-997.
34. Dulloo, A. G.; Duret, C.; Rohrer, D.; Girardier, L.; Mensi, N.; Fathi, M.; Chantre, P.; Vandermander, J. Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans. Am. J. Clin. Nutr. 1999, 70, 1040-11015
35. (35) Toyoda-Ono, Y.; Yoshimura, M.; Nakai, M.; Fukui, Y.; Asami, S.; Shibata, H.; Kiso, Y.; Ikeda, I. Suppression of postprandial hypertriglyceridemia in rats and mice by oolong tea polymerized polyphenols, Biosci. Biotechnol. Biochem. 2007, 71, 971-976. (Pubitemid 46650946)
36. Bassoli, B. K.; Cassolla, P.; Borba-Murad, G. R.; Constantin, J.; Salgueiro-Pagadigorria, C. L.; Bazotte, R. B.; da Silva, R. S.; de Souza, H. M. Chlorogenic acid reduces the plasma glucose peak in the oral glucose tolerance test: effects on hepatic glucose release and glycaemia. Cell Biochem. Funct. 2008, 26, 320-328.
37. Schulze, M. B.; Hoffmann, K.; Manson, J. E.; Willett, W. C.; Meigs, J. B.; Heidemann, C.; Colditz, G. A.; Hu, F. B. Dietary pattern, inflammation, and incidence of type 2 diabetes in women. Am J. Clin. Nutr. 2005, 82 (3), 675-684.
38. (38) Kamei, N.; Tobe, K.; Suzuki, R; Ohsugi, M.; Watanabe, T.; Kubota, N; Ohtsuka-Kowatari, N.; Kumagai, K.; Sakamoto, K.; Kobayashi, M.; Yamauchi, T.; Ueki, K.; Oishi, Y.; Nishimura, S.; Manabe, I.; Hashimoto, H.; Ohnishi, Y.; Ogata, H.; Tokuyama, K.; Tsunoda, M.; Ide, T.; Murakami, K.; Nagai, R.; Kadowaki, T. Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. J. Biol. Chem. 2006, 281, 26602-26614. (Pubitemid 44401869)
39. (39) van Dam, R. M.; Dekker, J. M.; Nijpels, G; Stehouwer, C. D.; Bouter, L. M.; Heine, R. J. Hoorn study. Coffee consumption and incidence of impaired fasting glucose, impaired glucose tolerance, and type 2 diabetes: the Hoorn Study, Diabetolgia 2004, 47, 2152-2159. (Pubitemid 40174688)
40. Arnlov, J.; Vessby, B.; Riserus, U. Coffee consumption and insulin sensitivity. JAMA, J. Am. Med. Assoc. 2004, 291, 1199-1201.
41. dos Santos, M., D.; Almeida, M. C.; Lopes, N. P.; de Souza, G. E. Evaluation of the anti-inflammatory, analgesic and antipyretic activities of the natural polyphenol chlorogenic acid. Biol. Pharm. Bull. 2006, 29, 2236-2240.
42. (42) Kurozawa, Y.; Ogimoto, I.; Shibata, A.; Nose, T.; Yoshimura, T.; Suzuki, H.; Sakata, R.; Fujita, Y.; Ichikawa, S.; Iwai, N.; Tamakoshi, A.; JACC Study Group. Coffee and risk of death from hepatocellular carcinoma in a large cohort study in Japan. Br. J. Cancer 2005, 93, 607-610. (Pubitemid 43080007)
43. (43) Shimazu, T.; Tsubono, Y.; Kuriyama, S.; Ohmori, K.; Koizumi, Y.; Nishino, Y.; Shibuya, D.; Tsuji, I. Coffee consumption and the risk, of primary liver cancer: Pooled analysis of two prospective studies in Japan. Int. J. Cancer 2005, 116, 150-154. (Pubitemid 40827769)
44. Inoue, M.; Yoshimi, I.; Sobue, T.; Tsugane, S. JPHC Study Group. Influence of coffee drinking on subsequent risk of hepatocellular carcinoma: a prospective study in Japan. J. Natl. Cancer Inst. 2005, 97, 293-300.
45. Tanaka, T.; Nishikawa, A.; Shima, H.; Sugie, S.; Shinoda, T.; Yoshimi, N.; Iwata, H.; Mori, H. Inhibitory effects of chlorogenic acid, reserpine, polyprenoic acid (E-5166), or coffee on hepatocarcinogenesis in rats and hamsters. Basic Life Sci. 1990, 52, 429-440.